Predicted protein targets (top 15)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TYR | P14679 | 1/20 | 0.72 |
| ▸ | MAPT | P10636 | 2/20 | 0.68 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.68 |
| ▸ | MAOB | P27338 | 2/20 | 0.59 |
| ▸ | AR | P10275 | 2/20 | 0.58 |
| ▸ | CHRNA7 | P36544 | 3/20 | 0.58 |
| ▸ | CYP1B1 | Q16678 | 1/20 | 0.55 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.53 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.53 |
| ▸ | LMNA | P02545 | 1/20 | 0.53 |
| ▸ | PKM | P14618 | 1/20 | 0.53 |
| ▸ | GRM5 | P41594 | 1/20 | 0.53 |
| ▸ | MEN1 | O00255 | 1/20 | 0.51 |
| ▸ | HSP90AA1 | P07900 | 1/20 | 0.51 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.51 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29837044 | 1.00 | TYR (0.72) | TYRMAPTMAPK1MAOBAR | |
| SCHEMBL21647110 | 1.00 | TYR (0.72) | TYRMAPTMAPK1MAOBAR | |
| SCHEMBL21647133 | 0.88 | MAPT (0.68) | TYRMAPTMAPK1MAOBAR | |
| SCHEMBL21647132 | 0.88 | MAPT (0.68) | TYRMAPTMAPK1MAOBAR | |
| SCHEMBL656139 | 0.86 | LMNA (0.70) | TYRMAPTMAPK1MAOBCYP1B1 | |
| SCHEMBL656140 | 0.86 | LMNA (0.70) | TYRMAPTMAPK1MAOBCYP1B1 | |
| SCHEMBL3995353 | 0.84 | TYR (1.00) | TYRCHRNA7PKMKMT2A | |
| SCHEMBL7925073 | 0.84 | TYR (1.00) | TYRCHRNA7PKMKMT2A | |
| SCHEMBL21446825 | 0.84 | TYR (1.00) | TYRCHRNA7PKMKMT2A | |
| SCHEMBL27737862 | 0.83 | MAPT (0.57) | TYRMAPTMAPK1MAOBAR |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 12 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-114890975-B | Compound with fused ring chroman structure and preparation method thereof | 合肥工业大学 | 2023-07-18 | — | — | CN | claimed |
| CN-114890975-A | Compound with parachroman structure and preparation method thereof | 合肥工业大学 | 2022-08-12 | — | — | CN | claimed |
| CN-114890975-B | Compound with fused ring chroman structure and preparation method thereof | 合肥工业大学 | 2023-07-18 | — | — | CN | disclosed |
| US-11485722-B2 | Cyclopenta[c]chromium compound and preparation method therefor | SOOCHOW UNIVERSITY (CN) | 2022-11-01 | — | — | US | disclosed |
| CN-114890975-A | Compound with parachroman structure and preparation method thereof | 合肥工业大学 | 2022-08-12 | — | — | CN | disclosed |
| US-11358945-B2 | Method for preparing cyclopenta[c]chromium compound | SOOCHOW UNIVERSITY (CN) | 2022-06-14 | — | — | US | disclosed |
| CN-108774207-B | Cyclopenta [ c ] chromene compounds and process for preparing the same | 苏州大学张家港工业技术研究院 | 2021-12-17 | — | — | CN | disclosed |
| US-20210147376-A1 | CYCLOPENTA[C]CHROMIUM COMPOUND AND PREPARATION METHOD THEREFOR | SOOCHOW UNIVERSITY (CN) | 2021-05-20 | — | — | US | disclosed |
| US-20210147377-A1 | METHOD FOR PREPARING CYCLOPENTA[C]CHROMIUM COMPOUND | SOOCHOW UNIVERSITY (CN) | 2021-05-20 | — | — | US | disclosed |
| WO-2020024100-A1 | METHOD FOR PREPARING CYCLOPENTADIENYL [C] CHROMIUM COMPOUND | 南通纺织丝绸产业技术研究院 | 2020-02-06 | — | — | WO | disclosed |
| WO-2020024099-A1 | CYCLOPENTADIENYL [C] CHROMIUM COMPOUND AND PREPARATION METHOD THEREFOR | 苏州大学张家港工业技术研究院 | 2020-02-06 | — | — | WO | disclosed |
| CN-1816328-A | Therapeutic agent | TAKARA BIO INC (JP) | 2006-08-09 | — | — | CN | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20210147376-A1 | CYCLOPENTA[C]CHROMIUM COMPOUND AND PREPARATION METHOD THEREFOR | CDYL, LAS1L, YAP1 | TYR 430/4885MAPT 2920/4885MAPK1 2172/4885 |
| US-20210147377-A1 | METHOD FOR PREPARING CYCLOPENTA[C]CHROMIUM COMPOUND | CDYL, CDYL2, KDM4C | TYR 53/4885MAPT 4307/4885MAPK1 3197/4885 |
| US-11485722-B2 | Cyclopenta[c]chromium compound and preparation method therefor | CDYL, LAS1L, YAP1 | TYR 430/4885MAPT 2920/4885MAPK1 2172/4885 |
| US-11358945-B2 | Method for preparing cyclopenta[c]chromium compound | CDYL, CDYL2, KDM4C | TYR 53/4885MAPT 4307/4885MAPK1 3197/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.